Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc.
Johnson Matthey, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for furt...
Johnson Matthey, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 9, 2021. Such persons may also file a written request for a hearing on the application on or before February 9, 2021.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA
Federal Register
Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on November 2, 2020, Johnson Matthey, Inc., 2003 Nolte Drive West Deptford, New Jersey 08066-1742, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled substance
Drug code
Schedule
Gamma Hydroxybutyric Acid
2010
I
Marihuana
7360
I
Tetrahydrocannabinols
7370
I
Dihyromorphine
9145
I
Difenoxin
9168
I
Amphetamine
1100
II
Methamphetamine
1105
II
Lisdexamfetamine
1205
II
Methylphenidate
1724
II
Nabilone
7379
II
Norfentanyl
8366
II
Cocaine
9041
II
Codeine
9050
II
Dihydrocodeine
9120
II
Oxycodone
9143
II
Hydromorphone
9150
II
Diphenoxylate
9170
II
Ecgonine
9180
II
Hydrocodone
9193
II
Levorphanol
9220
II
Meperidine
9230
II
Methadone
9250
II
Methadone intermediate
9254
II
Morphine
9300
II
Thebaine
9333
II
Opium tincture
9630
II
Oxymorphone
9652
II
Noroxymorphone
9668
II
Alfentanil
9737
II
Remifentanil
9739
II
Sufentanil
9740
II
Tapentadol
9780
II
Fentanyl
9801
II
The company plans to bulk manufacture the listed controlled substances for the internal use intermediates or for sale to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.
21 CFR 1301.33(a)